Literature DB >> 19131997

Looking ahead in cancer stem cell research.

John E Dick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19131997     DOI： 10.1038/nbt0109-44

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  7 in total

Review 1.  Cancer stem cells: models and concepts.

Authors:  Piero Dalerba; Robert W Cho; Michael F Clarke
Journal:  Annu Rev Med       Date:  2007       Impact factor: 13.739

2.  The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.

Authors:  François Vaillant; Marie-Liesse Asselin-Labat; Mark Shackleton; Natasha C Forrest; Geoffrey J Lindeman; Jane E Visvader
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

3.  Comment on "Tumor growth need not be driven by rare cancer stem cells".

Authors:  James A Kennedy; Frédéric Barabé; Armando G Poeppl; Jean C Y Wang; John E Dick
Journal:  Science       Date:  2007-12-14       Impact factor: 47.728

4.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

Authors:  Xiaoxian Li; Michael T Lewis; Jian Huang; Carolina Gutierrez; C Kent Osborne; Meng-Fen Wu; Susan G Hilsenbeck; Anne Pavlick; Xiaomei Zhang; Gary C Chamness; Helen Wong; Jeffrey Rosen; Jenny C Chang
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

5.  Tumor growth need not be driven by rare cancer stem cells.

Authors:  Priscilla N Kelly; Aleksandar Dakic; Jerry M Adams; Stephen L Nutt; Andreas Strasser
Journal:  Science       Date:  2007-07-20       Impact factor: 47.728

Review 6.  Stem cell concepts renew cancer research.

Authors:  John E Dick
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

7.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962
  7 in total
  82 in total

1.  Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells.

Authors:  Yan Zhou; Jiyuan Yang; Jindřich Kopeček
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

2.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

3.  Will engineered T cells expressing CD20 scFv eradicate Melanoma?

Authors:  Rajasekharan Somasundaram; Jessie Villanueva; Meenhard Herlyn
Journal:  Mol Ther       Date:  2011-04       Impact factor: 11.454

4.  Maintenance of tumor initiating cells of defined genetic composition by nucleostemin.

Authors:  Naoko Okamoto; Mami Yasukawa; Christine Nguyen; Vivi Kasim; Yoshiko Maida; Richard Possemato; Tatsuhiro Shibata; Keith L Ligon; Kiyoko Fukami; William C Hahn; Kenkichi Masutomi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

5.  The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma.

Authors:  Qian Zhong; Zhi-Hua Liu; Zhi-Rui Lin; Ze-Dong Hu; Li Yuan; Yan-Min Liu; Ai-Jun Zhou; Li-Hua Xu; Li-Juan Hu; Zi-Feng Wang; Xin-Yuan Guan; Jia-Jie Hao; Vivian W Y Lui; Ling Guo; Hai-Qiang Mai; Ming-Yuan Chen; Fei Han; Yun-Fei Xia; Jennifer R Grandis; Xing Zhang; Mu-Sheng Zeng
Journal:  Clin Cancer Res       Date:  2017-11-13       Impact factor: 12.531

6.  Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells.

Authors:  S Mukherjee; A Manna; P Bhattacharjee; M Mazumdar; S Saha; S Chakraborty; D Guha; A Adhikary; D Jana; M Gorain; S A Mukherjee; G C Kundu; D K Sarkar; T Das
Journal:  Oncogene       Date:  2016-02-29       Impact factor: 9.867

Review 7.  Survivin as a novel target protein for reducing the proliferation of cancer cells.

Authors:  Dongyu Li; Chenghao Hu; Huibin Li
Journal:  Biomed Rep       Date:  2018-03-13

8.  HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects.

Authors:  Yan Zhou; Jiyuan Yang; Johng S Rhim; Jindřich Kopeček
Journal:  J Control Release       Date:  2013-09-14       Impact factor: 9.776

9.  Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.

Authors:  D D Fang; Y J Kim; C N Lee; S Aggarwal; K McKinnon; D Mesmer; J Norton; C E Birse; T He; S M Ruben; P A Moore
Journal:  Br J Cancer       Date:  2010-03-23       Impact factor: 7.640

10.  Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression.

Authors:  Aaron E Foster; Fatma V Okur; Ettore Biagi; An Lu; Gianpietro Dotti; Eric Yvon; Barbara Savoldo; George Carrum; Michael Andreeff; Margaret A Goodell; Helen E Heslop; Malcolm K Brenner
Journal:  Mol Cancer       Date:  2009-11-18       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.